Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06090461
Status:
COMPLETED
Last Update Posted:
2023-10-19
First Post:
2023-10-12
Brief Title:
Real-World Evidence on the Cardiovascular Safety of CONTRAVE in the United States US
Sponsor:
Currax Pharmaceuticals
Organization:
Currax Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-10-12
First Submit QC Date:
October 17 2023
Study First Post Date:
2023-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-17
Last Update Post Date:
2023-10-19
Last Update Post Date Type:
ACTUAL